| Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma T Robak, H Huang, J Jin, J Zhu, T Liu, O Samoilova, H Pylypenko, ... New England Journal of Medicine 372 (10), 944-953, 2015 | 423 | 2015 |
| Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled … E Mercuri, N Deconinck, ES Mazzone, A Nascimento, M Oskoui, K Saito, ... The Lancet Neurology 21 (1), 42-52, 2022 | 134 | 2022 |
| Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in … T Robak, J Jin, H Pylypenko, G Verhoef, N Siritanaratkul, J Drach, ... The Lancet Oncology 19 (11), 1449-1458, 2018 | 119 | 2018 |
| Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms S Sanabani, WK Neto, J Pereira, EC Sabino Journal of clinical microbiology 44 (2), 604-606, 2006 | 117 | 2006 |
| Randomized phase III study of alisertib or investigator’s choice (selected single agent) in patients with relapsed or refractory peripheral T-cell lymphoma OA O’Connor, M Özcan, ED Jacobsen, JM Roncero, J Trotman, J Demeter, ... Journal of Clinical Oncology 37 (8), 613, 2019 | 111 | 2019 |
| Comparison of subcutaneous versus intravenous administration of rituximab as maintenance treatment for follicular lymphoma: results from a two-stage, phase IB study A Salar, I Avivi, B Bittner, R Bouabdallah, M Brewster, O Catalani, ... Journal of Clinical Oncology, 2014 | 105 | 2014 |
| Reduction of erythroid progenitors in protein-energy malnutrition P Borelli, S Blatt, J Pereira, BB de Maurino, M Tsujita, AC de Souza, ... British Journal of Nutrition 97 (2), 307-314, 2007 | 98 | 2007 |
| Study of lymphocyte subpopulations in bone marrow in a model of protein-energy malnutrition RA Fock, SL Blatt, B Beutler, J Pereira, M Tsujita, FEV de Barros, P Borelli Nutrition 26 (10), 1021-1028, 2010 | 91 | 2010 |
| Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double … W Jurczak, I Moreira, GB Kanakasetty, E Munhoz, MA Echeveste, P Giri, ... The Lancet Haematology 4 (8), e350-e361, 2017 | 76 | 2017 |
| Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients MP Freire, LC Pierrotti, HHC Filho, KY Ibrahim, A Magri, PR Bonazzi, ... European Journal of Clinical Microbiology & Infectious Diseases 34, 277-286, 2015 | 70 | 2015 |
| Protein-energy malnutrition halts hemopoietic progenitor cells in the G0/G1 cell cycle stage, thereby altering cell production rates P Borelli, FEV Barros, K Nakajima, SL Blatt, B Beutler, J Pereira, M Tsujita, ... Brazilian Journal of Medical and Biological Research 42, 523-530, 2009 | 67 | 2009 |
| Mogamulizumab versus investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma AA Phillips, PA Fields, O Hermine, JC Ramos, BE Beltran, J Pereira, ... haematologica 104 (5), 993, 2019 | 66 | 2019 |
| Philodendron adamantinum (Araceae) lures its single cyclocephaline scarab pollinator with specific dominant floral scent volatiles J Pereira, C Schlindwein, Y Antonini, ACD Maia, S Dötterl, C Martins, ... Biological Journal of the Linnean Society 111 (3), 679-691, 2014 | 62 | 2014 |
| Single‐node vs. multi‐node centrality in landscape graph analysis: key habitat patches and their protection for 20 bird species in NE Spain J Pereira, S Saura, F Jordán Methods in Ecology and Evolution 8 (11), 1458-1467, 2017 | 54 | 2017 |
| Pathophysiology and molecular aspects of diffuse large B-cell lymphoma GR Gouveia, SAC Siqueira, J Pereira Revista brasileira de hematologia e hemoterapia 34, 447-451, 2012 | 54 | 2012 |
| Brazilian Cardio-oncology Guideline–2020 LA Hajjar, IBSS Costa, MACQ Lopes, PMG Hoff, MDPE Diz, ... Arquivos Brasileiros de Cardiologia 115, 1006-1043, 2020 | 47 | 2020 |
| Molecular characterization of human T-cell lymphotropic virus type 1 full and partial genomes by Illumina massively parallel sequencing technology R Pessôa, JT Watanabe, Y Nukui, J Pereira, J Kasseb, ... PLoS One 9 (3), e93374, 2014 | 44 | 2014 |
| How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation GF Perini, T Fischer, RD Gaiolla, TB Rocha, M Bellesso, LLC Teixeira, ... Hematology, Transfusion and Cell Therapy 42 (2), 103-110, 2020 | 42 | 2020 |
| Gerar Percursos Sociais: Programa de prevenção e reabilitação para jovens com comportamento social desviante [Growing Pro-Social: Prevention and rehabilitation program for … D Rijo, MN Sousa, J Lopes, J Pereira, J Vasconcelos, MC Mendonça, ... Ponta Delgada: EQUAL, 2007 | 42 | 2007 |
| Proceedings of the 3rd IPLeiria’s International Health Congress: Leiria, Portugal. 6-7 May 2016 CC Tomás, E Oliveira, D Sousa, M Uba-Chupel, G Furtado, C Rocha, ... BMC Health Services Research 16, 111-242, 2016 | 40* | 2016 |
Sérgio Paulo BydlowskiProfessor Associado de Hematologia, Faculdade de Medicina da Universidade de São PauloE-mail confirmado em usp.br
